Antibiotic control of tumor-colonizing Salmonella enterica serovar Typhimurium.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractSystemic administration of Salmonella enterica serovar Typhimurium (S. typhimurium) into tumor-bearing mice results in preferential colonization of tumors and causes shrinkage and sometimes complete tumor clearance. However, in spite of these beneficial antitumor effects, the systemic administration of a bacterial pathogen raises serious safety concerns as well. Addressing those concerns, here, we demonstrate that tumor-colonizing Salmonella can be readily controlled by systemic administration of the antibiotic - ciprofloxacin. Treatment was most effective when started early postinfection. This was achieved at the expense of the efficacy of tumor therapy. In many of the mice treated in such a way, tumors re-grew again. Nevertheless, some mice were able to clear the tumor despite the start of antibiotic treatment only 24 h after the start of infection. Furthermore, we could demonstrate that such mice had elicited a specific antitumor immune response. Thus, S. typhimurium-mediated tumor therapy might be applied safely when combined with early antibiotic treatment. However, the therapeutic power of the bacteria needs to be enhanced in order to provide a more effective therapeutic tool.
CitationAntibiotic control of tumor-colonizing Salmonella enterica serovar Typhimurium. 2011, 236 (11):1282-90 Exp. Biol. Med. (Maywood)
The following license files are associated with this item:
- Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium.
- Authors: Crull K, Bumann D, Weiss S
- Issue date: 2011 Jun
- Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection.
- Authors: de LeBlanc Ade M, Castillo NA, Perdigon G
- Issue date: 2010 Apr 15
- Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not.
- Authors: Endt K, Maier L, Käppeli R, Barthel M, Misselwitz B, Kremer M, Hardt WD
- Issue date: 2012 May
- Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi.
- Authors: Marathe SA, Kumar R, Ajitkumar P, Nagaraja V, Chakravortty D
- Issue date: 2013 Jan
- Treatment of severe Salmonella typhimurium infection with ciprofloxacin.
- Authors: Dutta P, Saha MR, Mitra U, Rasaily R, Bhattacharya SK, Bhattacharya MK, Kundu B, Gupta A
- Issue date: 1995 Jul